Wijdeveld, M. (2023). Gut-brain interactions affecting metabolic health and central appetite regulation in diabetes, obesity and aging. [Thesis, fully internal, Universiteit van Amsterdam].
Meijnikman, A. S. (2023). A panomics step to unravel the role of gut microbiota in metabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].
Boulund, U. (2023). Exploring high dimensional data in health and disease: From genome to microbiome. [Thesis, fully internal, Universiteit van Amsterdam].
Wortelboer, K. (2023). Faecal matters: How transplanting gut bacteria and their viruses impacts cardiometabolic disease. [Thesis, fully internal, Universiteit van Amsterdam].
Meiring, S. (2023). Clinical and mechanistic studies of duodenal mucosal resurfacing for type 2 diabetes. [Thesis, fully internal, Universiteit van Amsterdam].
van Olden, C. C. (2023). Obesity and insulin resistance: Intermediate hyperglycaemia in populations and ageing tissuers. [Thesis, fully internal, Universiteit van Amsterdam].
van Dijk, A.-M. (2023). Navigating NAFLD non-invasively: Ingredients to shape future care paths in non-alcoholic fatty liver disease. [Thesis, fully internal, Universiteit van Amsterdam].
Houttu, V. (2023). Dissecting the interplay of exercise, gut microbiota and NAFLD. [Thesis, fully internal, Universiteit van Amsterdam].
Koopen, A. M. (2022). Gut microbiota in insulin sensitivity. [Thesis, fully internal, Universiteit van Amsterdam].
Gilijamse, P. W. (2022). Assessing and targeting insulin resistance. [Thesis, fully internal, Universiteit van Amsterdam].
